AstraZeneca plc (ADR) (AZN)

TMFBreakerBeth (87.77) Submitted: 5/18/06 12:27 PM : Start Price: $49.93 AZN Score: -25.28

Among the other things I like about AZN, if it gains FDA approval to promote Seroquel for bipolar disorder, I think that will open up a huge market. There's a big educational project underway to raise awareness about bipolar-2 -- the likely culprit ...

Report this Post Replies: 2 | Reply | Permalink

omoplata (24.21) Submitted: 4/10/07 12:45 PM : Start Price: $51.66 AZN Score: -14.38

Stock is undervalued.

Report this Post Replies: 0 | Reply | Permalink

leeleming (< 20) Submitted: 9/04/06 3:02 AM : Start Price: $60.41 AZN Score: -36.37

Solid pipeline and excellent leadership - attracting key talent from major pharma

Report this Post Replies: 0 | Reply | Permalink

flexnexus (< 20) Submitted: 3/15/07 10:46 PM : Start Price: $53.77 AZN Score: 21.39

While AZN has made a smart deal with Palatin (PTN), I'm generally bearish on big pharma. Lots of legislation is going to come about that will cost them a lot of money.

Report this Post Replies: 0 | Reply | Permalink

pfxlovell (81.03) Submitted: 3/16/07 3:41 PM : Start Price: $53.26 AZN Score: -21.12

Looking to acquire biotechs to enhance pipeline. Solid company - great management.

Report this Post Replies: 0 | Reply | Permalink

marionvb (95.94) Submitted: 4/06/07 4:50 PM : Start Price: $51.67 AZN Score: 14.31

They may need some Levitra as some of their drugs go off patent.

Report this Post Replies: 1 | Reply | Permalink

OhioSt88 (< 20) Submitted: 5/10/07 11:33 AM : Start Price: $51.05 AZN Score: -9.53

Undervalued. Continuously reports strong earnings and is developing and buying a pipeline with innovation.

Report this Post Replies: 0 | Reply | Permalink

NetscribePhrmtcl (39.30) Submitted: 5/23/07 9:13 AM : Start Price: $51.42 AZN Score: -8.56

British drugmaker AstraZeneca is all set to acquire MedImmune for all-cash transaction with a total enterprise value of $15.2 billion. AstraZeneca will acquire all shares of MedImmune at a price of $58 per share, aggregating to a total consideration ...

Report this Post Replies: 0 | Reply | Permalink

boca7rel (24.11) Submitted: 5/26/07 3:08 PM : Start Price: $51.05 AZN Score: -8.56

cheap earnings compared to industry sector. Low debt to equity ratio

Report this Post Replies: 0 | Reply | Permalink

BUYBELOW (< 20) Submitted: 6/18/07 5:00 PM : Start Price: $49.65 AZN Score: -5.78

A Value play that pays as you wait . Low p/e compared to its peers.

Report this Post Replies: 0 | Reply | Permalink